Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Clinical Trial Ended for Prostate Cancer Vaccine
Biotech startup Cell Genesys has ended a clinical study of its prostate cancer vaccine GVAX due to a...
-- Here are the latest clinical trials, courtesy of CenterWatch:
Eczema (Atopic Dermatitis)
If you are aged 18 to 65, have eczema, and are in good general health, you may be eligible for this study.
The research site is in Raleigh, N.C.
More...
THURSDAY, Aug. 28 -- All antipsychotic drugs can increase the risk of stroke, but the risk is greatest among older patients with dementia, British researchers report.
Concerns about the risk of stroke and antipsychotics were first raised in 2002,...
WEDNESDAY, Aug. 27 -- Patients with multiple myeloma who could not tolerate high dose chemotherapy lived longer and better by adding the drug Velcade to standard treatment, a new study found.
The finding could make multiple myeloma, a cancer of the...
WEDNESDAY, Aug. 27 -- The blood pressure drug telmisartan does not lower the rate of stroke, cardiovascular events or diabetes better than a placebo in patients who have had a stroke, a new study finds.
Telmisartan is an angiotensin II receptor...
Pharma Industry News
LONDON, & ALISO VIEJO, California, Aug. 28, 2008-GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International (NYSE: VRX) today announced that they have entered into an exclusive worldwide collaboration agreement for the investigational drug...
NICE Final Guidance Recommends Lucentis As Cost-Effective Treatment for Wet AMD, a Leading Cause of Blindness
Lucentis is only approved therapy to demonstrate improvement in vision and vision-related function in vast majority of wet AMD...
- Clinical data showing unprecedented 89% reduction in risk of GIST relapse with use of Gleevec after surgery are basis for FDA, EMEA, Swissmedic filings
EAST HANOVER, N.J., August 27, 2008 /PRNewswire/ -- Novartis announced today that Gleevec(R)...
SAN DIEGO and INDIANAPOLIS, August 26, 2008 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. and Eli Lilly and Company in a conference call today provided context and additional information regarding the August 18, 2008 U.S. Food and Drug...
Information for Healthcare Professionals Natalizumab Injection for Intraveneous Use (marketed as Tysabri)
ROCKVILLE, Md., Aug. 25, 2008--FDA ALERT [8/2008]: The FDA has recently received information from the manufacturer about two new cases of...
New Drug Approvals
WOODCLIFF LAKE, N.J., August 23, 2008 /PRNewswire/ -- Eisai Corporation of North America and its partner Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved a new oral formulation of Aloxi...
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Aug 22, 2008 - Amgen Inc. (NASDAQ: AMGN) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nplate (romiplostim), the first and only platelet producer for the...
SUMMIT, N.J.--(BUSINESS WIRE)--Aug 21, 2008 - Celgene Corporation today announced Vidaza (azacitidine) received expanded U.S. Food and Drug Administration (FDA) approval to reflect new overall survival achieved in the AZA-001 survival study of...
WASHINGTON, August 15, 2008 /PRNewswire/ -- Prestwick Pharmaceuticals, Inc., a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Xenazine (tetrabenazine) for the treatment of chorea...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug 11, 2008 - Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Viread (tenofovir disoproxil fumarate) for the treatment of chronic...
New Drug Applications
RALEIGH, N.C.--(BUSINESS WIRE)--Aug. 28, 2008 - BioDelivery Sciences International, Inc. (Nasdaq:BDSI) today announced receipt of a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the Company's New Drug...
TITUSVILLE, N.J., August 26, 2008 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that the Food and Drug Administration (FDA) has asked for additional data before it will approve the company's...
VANCOUVER and DEERFIELD, IL, August 11, 2008 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. and its co-development partner Astellas Pharma US, Inc. ("Astellas") today announced that they have received an action letter dated August 8, 2008 from the...
BRIDGEWATER, N.J., August 08, 2008 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that U.S. Food and Drug Administration (FDA) has assigned priority review status for its New Drug Application (NDA) for Multaq (dronedarone). The priority...
HORSHAM, Pa., August 08, 2008 /PRNewswire/ -- Centocor, Inc., today announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline for the Biologic License Application for ustekinumab, a subcutaneous biologic therapy, by...
Clinical Trials
MONTREAL, Aug. 28 /CNW Telbec/ - Immunotec Inc. (TSX-V: IMM) announced today the completion of an open-label clinical trial on the use of a cysteine-rich protein isolate in children with autism. Ten children, 3-15 years of age with a diagnosis of...
BETHESDA, Md., Aug. 27, 2008--A brain chemical that plays a role in long term memory also appears to be involved in regulating how much people eat and their likelihood of becoming obese, according to a National Institutes of Health study of a rare...
Further validation of Heptares' StaRT technology
LONDON, Aug. 28, 2008--Heptares Therapeutics Ltd, the drug discovery company focused on the design and development of novel drugs based on G-protein-coupled receptors (GPCRs), notes that a new...
Results Presented at the Australian and New Zealand Bone and Mineral Society (ANZBMS) Annual Meeting
HOPKINTON, Mass., Aug. 28 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc., , announced that data from preclinical studies of the Company's...
WARREN, N.J.--(BUSINESS WIRE)--Aug 28, 2008 - In patients with diabetes, the CYPHER(R) Sirolimus-eluting Coronary Stent outperformed the Taxus(R) Stent with significantly lower rates of in-segment restenosis (a reblockage within the stented area),...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
